Honorable Mention Transforming AV Fistula Creation: The Ellipsys Vascular Access System

The gold standard for vascular access for hemodialysis is the arteriovenous fistula (AVF). It is preferred over synthetic grafts and central venous catheters because of its lower infection rate, prolonged survival, lower hospitalization rates and lower healthcare costs. 1 Until recently, however, AVF creation could only be done through an open surgical procedure that subjects patients to pain and discomfort. In addition, the longer recovery times, high failure rates and multiple interventions to successfully achieve maturation all contribute to delayed dialysis.

The Ellipsysa Vascular Access System represents a new approach to dialysis access by offering a minimally invasive approach to AVF creation. Approved by the FDA in 2018, Ellipsys is one of the few significant innovations in hemodialysis access in decades. The procedure uses an endovascular approach to create an AV fistula, making it a faster, more efficient and less invasive alternative to surgery. The ability to create a functional AVF without surgery or implants offers quality-of-life benefits for patients and can provide advantages for physicians, dialysis providers and payers.

Learn more at avenumedical.com